Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
Dentons
The Federal Court has issued a rebuke of competitors involved in a merger which cooperate or coordinate their conduct before the merger is complete.
Hogan Lovells
The Minister of Health, Dr Aaron Motsoaledi (Minister), has been entrusted with the unenviable task of overseeing South Africa's transition to universal health coverage
Gowling WLG
In late 2018, a series of news articles took aim at Canada's regulation of medical devices, alleging that Health Canada's medical device approval and adverse event monitoring systems were severely
Norton Rose Fulbright Canada LLP
Notre groupe organise une conférence bien spéciale le 22 mai prochain sur les conséquences de l'intersection entre la santé et l'intelligence artificielle
Singh & Associates
On April 23, 2019, Indian Council of Medical Research (ICMR) licensed the technology for Shigella vaccine for further scaling up and commercialisation to MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
S Horowitz & Co
The Israeli Patents Law 1967 empowers the Registrar of Patents to extend the term of 'basic patents' protecting pharmaceutical products, for an additional term beyond the statutory 20-year period of patent protection.
Arnold & Porter
The Arnold & Porter Future Pharma Forum provides training and networking opportunities for junior and mid-level lawyers in the life sciences industry.
Arnold & Porter
Apologies that it has been a while since we've posted! We have lots in the pipeline, starting with this webinar.
Brahams Dutt Badrick French LLP
Acas has published new guidance on handling neurodiversity in the workplace. Neurodiversity refers to different ways the brain can use and interpret information. This includes attention deficit
Oblon, McClelland, Maier & Neustadt, L.L.P
Often in writing applications there is a tendency to denigrate prior art techniques.
BakerHostetler
Below is this week's "Capitol Hill Healthcare Update," which is posted on Mondays when Congress is in session.
Fish & Richardson PC
Decisions in the Amgen v. Sandoz case involving Sandoz's biosimilar versions of Amgen's Neupogen® and Neulasta® drugs have provided significant guidance to biosimilar litigants over the years.
Pearl Cohen Zedek Latzer Baratz
Under the terms of the research pact, Orgenesis will receive an exclusive license on the technology developed at Columbia.
Reed Smith
Today's case in a nutshell is the dismissal on forum non conveniens grounds of a claim brought in the United States by a woman from a Spain.
Foley & Lardner
The Personalized Medicine Coalition, or the "PMC" is an organization of over 250 members that seeks to promote the understanding and adoption of personalized or precision medicine concepts, services,
BakerHostetler
The acting commissioner covered opioids, the safety of imported foods and possible changes to the cosmetics regulatory regime during his address to attendees at the 2019 FDLI Annual Conference.
Ropes & Gray LLP
On April 24, 2019, the Food and Drug Administration ("FDA") released a draft guidance, entitled "Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C,"
Singh & Associates
On April 12, 2019, the USFDA granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration ...
Oblon, McClelland, Maier & Neustadt, L.L.P
James Love wrote an article entitled "Patent Strategy and The Internet of Medical Things," featured in Med Device Online.
Reed Smith
Agency Promises More Frequent Drug/Device HCPCS Code Update Opportunities, Bars MACs from Adopting New Blanket Noncoverage Policies without Evidence Review
Latest Video
Most Popular Recent Articles
Reed Smith
Today, Reed Smith is hosting a client roundtable in London, "Identifying and Mitigating Risk in a Changing Global Economy," for life sciences clients.
Venner Shipley LLP
The President of the European Patent Office has submitted questions to the Enlarged Board of Appeal which relate to the patentability of plants exclusively obtained by essentially biological processes and to T1063/18, ...
Arnold & Porter
For all the headlines and law firm advisories that pore over the Department of Justice's (DOJ) annual False Claims Act (FCA) ...
Reed Smith
If the promise of adaptive artificial intelligence (sometimes called "Machine Learning") is to be achieved in the medical area, FDA's regulation of medical devices is going to have to graduate from
Hogan Lovells
Hogan Lovells has been at the forefront of advising our clients on the clearance or approval of an increasing number of software as a medical device products and other medical devices that incorporate AI/ML algorithms
Cooley LLP
That's because, in 2016, the House passed the Fostering Innovation Act of 2015—the very same bill.
Fasken
On March 19, 2019, federal Finance Minister William Morneau tabled the latest federal budget in the House of Commons ("Budget 2019"),
Reed Smith
That's what we thought when we ran across Restatement §920 recently – it was by accident; we were researching something else.
Ropes & Gray LLP
On March 19, 2019, Senators Chuck Grassley (R-IA) and Ron Wyden (D-OR) of the Senate Finance Committee ("SFC") wrote a letter (the "POD Letter") to the HHS Office of Inspector General ("OIG")
Wilson Elser Moskowitz Edelman & Dicker LLP
With increased reliance on telemedicine, many physicians question whether the elimination of in-office, face-to-face patient encounters increases their potential medical practice liability risks.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter